Opus Genetics (IRD) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.97% |
| Dec 31, 2025 | -46.40% |
| Sep 30, 2025 | 5.02% |
| Jun 30, 2025 | 22.42% |
| Mar 31, 2025 | -37.85% |
| Dec 31, 2024 | 17.16% |
| Sep 30, 2024 | 11.62% |
| Jun 30, 2024 | 12.20% |
| Mar 31, 2024 | 6.63% |
| Dec 31, 2023 | -19.11% |
| Sep 30, 2023 | -5.97% |
| Jun 30, 2023 | -2.59% |
| Mar 31, 2023 | 8.61% |
| Dec 31, 2022 | -205.84% |
| Sep 30, 2022 | 18.63% |
| Jun 30, 2022 | 11.51% |
| Mar 31, 2022 | 21.70% |
| Dec 31, 2021 | -9.37% |
| Sep 30, 2021 | 6.61% |
| Jun 30, 2021 | -128.69% |
| Mar 31, 2021 | 35.38% |
| Dec 31, 2020 | -102.97% |
| Sep 30, 2020 | 12.26% |
| Jun 30, 2020 | 16.27% |
| Mar 31, 2020 | -142.56% |
| Dec 31, 2019 | 67.41% |
| Sep 30, 2019 | 14.43% |
| Jun 30, 2019 | 9.74% |
| Mar 31, 2019 | -22.34% |
| Dec 31, 2018 | -17.19% |
| Sep 30, 2018 | 24.94% |
| Jun 30, 2018 | 20.97% |
| Mar 31, 2018 | 21.05% |
| Dec 31, 2017 | -15.63% |
| Sep 30, 2017 | 13.34% |
| Jun 30, 2017 | -44.72% |
| Mar 31, 2017 | 8.92% |
| Dec 31, 2016 | 6.86% |
| Sep 30, 2016 | -12.44% |
| Jun 30, 2016 | 20.72% |
| Mar 31, 2016 | -4.39% |
| Dec 31, 2015 | -9.24% |
| Sep 30, 2015 | 17.42% |
| Jun 30, 2015 | 11.57% |
| Mar 31, 2015 | 10.13% |
| Dec 31, 2014 | 8.11% |
| Sep 30, 2014 | 6.86% |
| Jun 30, 2014 | 4.90% |
| Mar 31, 2014 | -113.82% |
| Dec 31, 2013 | -25.50% |
| Sep 30, 2013 | -48.53% |
| Jun 30, 2013 | 17.17% |
| Mar 31, 2013 | 10.43% |
| Dec 31, 2012 | -81.64% |
| Sep 30, 2012 | 12.85% |
| Jun 30, 2012 | 14.61% |
| Mar 31, 2012 | 14.90% |
| Dec 31, 2011 | 22.12% |
| Sep 30, 2011 | 16.10% |
| Jun 30, 2011 | 11.87% |
| Mar 31, 2011 | -38.68% |
| Dec 31, 2010 | 6.56% |
| Sep 30, 2010 | 11.14% |